Jeannette L. Tenthorey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jeannette L. Tenthorey has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Harmit Singh Malik
Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA
7 shared publications - Michael Emerman
Divisions of Basic Sciences and Human Biology, Fred Hutchinson Cancer Center
7 shared publications - Russell E. Vance
Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA
3 shared publications Afeez Sodeinde
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States
2 shared publicationsCandice Young
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States
2 shared publications- Caroline A. Langley
Molecular and Cellular Biology Graduate Program, University of Washington
2 shared publications
Latest Publications
- Open Access
- 2 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (18) , eadu0062
Heterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction
Antiviral restriction factors such as MxA (myxovirus resistance protein A) inhibit many viruses. Viral escape drives restriction factors to evolve rapidly at virus-binding interfaces to regain defense. Here, we explore how antiviral proteins balance restricting many viruses with evolving specificity against individual viruses. Human MxA uses its rapidly evolving loop L4 as the specificity determinant for orthomyxoviruses such as thogotovirus (THOV) and influenza (IAV). Previous combinatorial mutagenesis of rapidly evolving residues in human MxA loop L4 identified THOV “super-restrictors” and suggested an antiviral breadth-specificity trade-off. Using a modified combinatorial mutagenesis strategy, we find super-restrictor MxA variants specific to H5N1 IAV. A single L4 residue underlies the MxA breadth-specificity trade-off. However, rare “generalist” super-restrictors or a heterozygous combination of more common “specialist” super-restrictors can overcome the breadth-specificity trade-off. Our findings suggest that at least two strategies enable restriction factors such as MxA to increase their restriction of diverse viruses to overcome breadth-specificity trade-offs, which might be pervasive in host-virus conflicts.
- 2 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (18) , eadu0062
Open AccessHeterozygous and generalist MxA super-restrictors overcome breadth-specificity trade-offs in antiviral restriction
Antiviral restriction factors such as MxA (myxovirus resistance protein A) inhibit many viruses. Viral escape drives restriction factors to evolve rapidly at virus-binding interfaces to regain defense. Here, we explore how antiviral proteins balance restricting many viruses with evolving specificity against individual viruses. Human MxA uses its rapidly evolving loop L4 as the specificity determinant for orthomyxoviruses such as thogotovirus (THOV) and influenza (IAV). Previous combinatorial mutagenesis of rapidly evolving residues in human MxA loop L4 identified THOV “super-restrictors” and suggested an antiviral breadth-specificity trade-off. Using a modified combinatorial mutagenesis strategy, we find super-restrictor MxA variants specific to H5N1 IAV. A single L4 residue underlies the MxA breadth-specificity trade-off. However, rare “generalist” super-restrictors or a heterozygous combination of more common “specialist” super-restrictors can overcome the breadth-specificity trade-off. Our findings suggest that at least two strategies enable restriction factors such as MxA to increase their restriction of diverse viruses to overcome breadth-specificity trade-offs, which might be pervasive in host-virus conflicts.
- Open Access
- 27 March 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (6) , 100818
Indels allow antiviral proteins to evolve functional novelty inaccessible by missense mutations
- 27 March 2025
- Published by Elsevier in Cell Genomics
- Vol. 5 (6) , 100818
Open AccessIndels allow antiviral proteins to evolve functional novelty inaccessible by missense mutations
- Open Access
- 24 January 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (4)
Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes
Mx proteins, first identified in mammals, encode potent antiviral activity against a wide range of viruses. Mx proteins arose within the Dynamin superfamily of proteins (DSP), which mediate critical cellular processes, such as endocytosis and mitochondrial, plastid, and peroxisomal dynamics. Despite their crucial role, the evolutionary origins of Mx proteins are poorly understood. Through comprehensive phylogenomic analyses with progressively expanded taxonomic sampling, we demonstrate that Mx proteins predate the interferon signaling system in vertebrates. Our analyses find an ancient monophyletic DSP lineage in eukaryotes that groups vertebrate and invertebrate Mx proteins with fungal MxF proteins, the largely uncharacterized plant and algal Dynamin 4A/4C proteins, and representatives from several other eukaryotic lineages, suggesting that Mx-like proteins date back close to the origin of Eukarya. Our phylogenetic analyses also find host-encoded and nucleocytoplasmic large DNA viruses-encoded DSPs interspersed in four distinct DSP lineages, indicating recurrent viral theft of host DSPs. Our analyses thus reveal an ancient history of viral and antiviral functions encoded by the Dynamin superfamily in eukaryotes.
- 24 January 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (4)
Open AccessAntiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes
Mx proteins, first identified in mammals, encode potent antiviral activity against a wide range of viruses. Mx proteins arose within the Dynamin superfamily of proteins (DSP), which mediate critical cellular processes, such as endocytosis and mitochondrial, plastid, and peroxisomal dynamics. Despite their crucial role, the evolutionary origins of Mx proteins are poorly understood. Through comprehensive phylogenomic analyses with progressively expanded taxonomic sampling, we demonstrate that Mx proteins predate the interferon signaling system in vertebrates. Our analyses find an ancient monophyletic DSP lineage in eukaryotes that groups vertebrate and invertebrate Mx proteins with fungal MxF proteins, the largely uncharacterized plant and algal Dynamin 4A/4C proteins, and representatives from several other eukaryotic lineages, suggesting that Mx-like proteins date back close to the origin of Eukarya. Our phylogenetic analyses also find host-encoded and nucleocytoplasmic large DNA viruses-encoded DSPs interspersed in four distinct DSP lineages, indicating recurrent viral theft of host DSPs. Our analyses thus reveal an ancient history of viral and antiviral functions encoded by the Dynamin superfamily in eukaryotes.
- Open Access
An all-atom view into the disordered interaction interface of the TRIM5 α PRYSPRY domain and the HIV capsid
Tripartite motif-containing protein 5, alpha isoform (TRIM5 α ) is an innate immune factor that provides rhesus macaques with immunity to HIV. Despite high sequence similarity to rhesus TRIM5 α , human TRIM5 α weakly restricts HIV without the introduction of mutations. The structural underpinnings of this functional difference are poorly understood because the interaction interface between TRIM5 α and its target, the HIV capsid, involves intrinsically disordered regions. Here, we use all-atom molecular dynamics simulations to study several TRIM5 α variants: rhesus TRIM5 α , human TRIM5 α , and human TRIM5 α with an R332P mutation (a mutation known to enhance HIV restriction). Our data reveal differences in the conformational ensembles of wild-type and R332P human TRIM5 α , including a significant increase in the formation of a turn that includes the mutation site residue. We also carried out simulations of rhesus TRIM5 α in complex with the HIV capsid protein. Our results indicate that the variable loops of TRIM5 α are highly flexible, both in solution and in the complex with the capsid, indicative of a fuzzy interaction interface. Simulations of the complex, as well as experimental infections, indicate the basis for weak HIV restriction by human TRIM5 α that is improved by an R332P mutation: replacing the positively charged arginine with a neutral residue decreases electrostatic repulsion with residue R82 of the capsid protein, which can be phenocopied by neutralizing mutations at capsid residue R82. Overall, our simulations provide a first view of the atomistic details of the HIV capsid-TRIM5 α binding interface and a molecular mechanism for the observed functional differences between variants of the TRIM5 α protein. Significance Statement: Humans and viruses are engaged in an evolutionary arms race, which involves evolutionary cycles in which viruses escape host defense and hosts evolve to chase after them. The protein TRIM5 α is a crucial part of the immune system’s defense against viruses, and the region of TRIM5 α that interacts with viral capsids is evolving rapidly. While a wealth of structural information is separately available for the HIV capsid protein and TRIM5 α , the interaction interface between these two proteins remains poorly understood because it involves multiple disordered regions. We present a first atomistic view of the TRIM5 α -capsid interaction interface using all-atom molecular dynamics simulations. We use our model of the interface and the probabilistic description of interactions to explain the improved HIV restriction of a mutation in the human TRIM5 α protein, which has been proposed for human gene therapy, in terms of specific electrostatic interactions. Finally, we validate our findings with experimental infections. Our data provide detailed structural insight into how TRIM5 evolves improved restriction against its retroviral targets.
Open AccessAn all-atom view into the disordered interaction interface of the TRIM5 α PRYSPRY domain and the HIV capsid
Tripartite motif-containing protein 5, alpha isoform (TRIM5 α ) is an innate immune factor that provides rhesus macaques with immunity to HIV. Despite high sequence similarity to rhesus TRIM5 α , human TRIM5 α weakly restricts HIV without the introduction of mutations. The structural underpinnings of this functional difference are poorly understood because the interaction interface between TRIM5 α and its target, the HIV capsid, involves intrinsically disordered regions. Here, we use all-atom molecular dynamics simulations to study several TRIM5 α variants: rhesus TRIM5 α , human TRIM5 α , and human TRIM5 α with an R332P mutation (a mutation known to enhance HIV restriction). Our data reveal differences in the conformational ensembles of wild-type and R332P human TRIM5 α , including a significant increase in the formation of a turn that includes the mutation site residue. We also carried out simulations of rhesus TRIM5 α in complex with the HIV capsid protein. Our results indicate that the variable loops of TRIM5 α are highly flexible, both in solution and in the complex with the capsid, indicative of a fuzzy interaction interface. Simulations of the complex, as well as experimental infections, indicate the basis for weak HIV restriction by human TRIM5 α that is improved by an R332P mutation: replacing the positively charged arginine with a neutral residue decreases electrostatic repulsion with residue R82 of the capsid protein, which can be phenocopied by neutralizing mutations at capsid residue R82. Overall, our simulations provide a first view of the atomistic details of the HIV capsid-TRIM5 α binding interface and a molecular mechanism for the observed functional differences between variants of the TRIM5 α protein. Significance Statement: Humans and viruses are engaged in an evolutionary arms race, which involves evolutionary cycles in which viruses escape host defense and hosts evolve to chase after them. The protein TRIM5 α is a crucial part of the immune system’s defense against viruses, and the region of TRIM5 α that interacts with viral capsids is evolving rapidly. While a wealth of structural information is separately available for the HIV capsid protein and TRIM5 α , the interaction interface between these two proteins remains poorly understood because it involves multiple disordered regions. We present a first atomistic view of the TRIM5 α -capsid interaction interface using all-atom molecular dynamics simulations. We use our model of the interface and the probabilistic description of interactions to explain the improved HIV restriction of a mutation in the human TRIM5 α protein, which has been proposed for human gene therapy, in terms of specific electrostatic interactions. Finally, we validate our findings with experimental infections. Our data provide detailed structural insight into how TRIM5 evolves improved restriction against its retroviral targets.
- Open Access
Heterozygous and generalist MxA super-restrictors overcome breadth-specificity tradeoffs in antiviral restriction
Antiviral restriction factors such as MxA (myxovirus resistance protein A) inhibit a broad range of viruses. However, they face the challenge of maintaining this breadth as viruses evolve to escape their defense. Viral escape drives restriction factors to evolve rapidly, selecting for amino acid changes at their virus-binding interfaces to regain defense. How do restriction factors balance the breadth of antiviral functions against the need to evolve specificity against individual escaping viruses? We explored this question in human MxA, which uses its rapidly evolving loop L4 as the specificity determinant for orthomyxoviruses such as THOV and IAV. Previous combinatorial mutagenesis of rapidly evolving residues in human MxA loop L4 revealed variants with a ten-fold increase in potency against THOV. However, this strategy did not yield improved IAV restriction, suggesting a strong tradeoff between antiviral specificity and breadth. Here, using a modified combinatorial mutagenesis strategy, we find ‘super-restrictor’ MxA variants with over ten-fold enhanced restriction of the avian IAV strain H5N1 but reduced THOV restriction. Analysis of super-restrictor MxA variants reveals that the identity of residue 561 explains most of MxA’s breadth-specificity tradeoff in H5N1 versus THOV restriction. However, rare ‘generalist’ super-restrictors with enhanced restriction of both viruses allow MxA to overcome the breadth-specificity tradeoff. Finally, we show that a heterozygous combination of two ‘specialist’ super-restrictors, one against THOV and the other against IAV, enhances restriction against both viruses. Thus, two strategies enable restriction factors such as MxA to increase their restriction of diverse viruses to overcome breadth-specificity tradeoffs that may be pervasive in host-virus conflicts.
Open AccessHeterozygous and generalist MxA super-restrictors overcome breadth-specificity tradeoffs in antiviral restriction
Antiviral restriction factors such as MxA (myxovirus resistance protein A) inhibit a broad range of viruses. However, they face the challenge of maintaining this breadth as viruses evolve to escape their defense. Viral escape drives restriction factors to evolve rapidly, selecting for amino acid changes at their virus-binding interfaces to regain defense. How do restriction factors balance the breadth of antiviral functions against the need to evolve specificity against individual escaping viruses? We explored this question in human MxA, which uses its rapidly evolving loop L4 as the specificity determinant for orthomyxoviruses such as THOV and IAV. Previous combinatorial mutagenesis of rapidly evolving residues in human MxA loop L4 revealed variants with a ten-fold increase in potency against THOV. However, this strategy did not yield improved IAV restriction, suggesting a strong tradeoff between antiviral specificity and breadth. Here, using a modified combinatorial mutagenesis strategy, we find ‘super-restrictor’ MxA variants with over ten-fold enhanced restriction of the avian IAV strain H5N1 but reduced THOV restriction. Analysis of super-restrictor MxA variants reveals that the identity of residue 561 explains most of MxA’s breadth-specificity tradeoff in H5N1 versus THOV restriction. However, rare ‘generalist’ super-restrictors with enhanced restriction of both viruses allow MxA to overcome the breadth-specificity tradeoff. Finally, we show that a heterozygous combination of two ‘specialist’ super-restrictors, one against THOV and the other against IAV, enhances restriction against both viruses. Thus, two strategies enable restriction factors such as MxA to increase their restriction of diverse viruses to overcome breadth-specificity tradeoffs that may be pervasive in host-virus conflicts.
- Open Access
Antiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes
First identified in mammals, Mx proteins are potent antivirals against a broad swathe of viruses. Mx proteins arose within the Dynamin superfamily of proteins (DSP), mediating critical cellular processes, such as endocytosis and mitochondrial, plastid, and peroxisomal dynamics. And yet, the evolutionary origins of Mx proteins are poorly understood. Using a series of phylogenomic analyses with stepwise increments in taxonomic coverage, we show that Mx proteins predate the interferon signaling system in vertebrates. Our analyses find an ancient monophyletic DSP lineage in eukaryotes that groups vertebrate and invertebrate Mx proteins with previously undescribed fungal MxF proteins, the relatively uncharacterized plant and algal Dynamin 4A/4C proteins, and representatives from several early-branching eukaryotic lineages. Thus, Mx-like proteins date back close to the origin of Eukarya. Our phylogenetic analyses also reveal that host-encoded and NCLDV (nucleocytoplasmic large DNA viruses)-encoded DSPs are interspersed in four distinct DSP lineages, indicating recurrent viral theft of host DSPs. Our analyses thus reveal an ancient history of viral and antiviral functions encoded by the Dynamin superfamily in eukaryotes.
Open AccessAntiviral Mx proteins have an ancient origin and widespread distribution among eukaryotes
First identified in mammals, Mx proteins are potent antivirals against a broad swathe of viruses. Mx proteins arose within the Dynamin superfamily of proteins (DSP), mediating critical cellular processes, such as endocytosis and mitochondrial, plastid, and peroxisomal dynamics. And yet, the evolutionary origins of Mx proteins are poorly understood. Using a series of phylogenomic analyses with stepwise increments in taxonomic coverage, we show that Mx proteins predate the interferon signaling system in vertebrates. Our analyses find an ancient monophyletic DSP lineage in eukaryotes that groups vertebrate and invertebrate Mx proteins with previously undescribed fungal MxF proteins, the relatively uncharacterized plant and algal Dynamin 4A/4C proteins, and representatives from several early-branching eukaryotic lineages. Thus, Mx-like proteins date back close to the origin of Eukarya. Our phylogenetic analyses also reveal that host-encoded and NCLDV (nucleocytoplasmic large DNA viruses)-encoded DSPs are interspersed in four distinct DSP lineages, indicating recurrent viral theft of host DSPs. Our analyses thus reveal an ancient history of viral and antiviral functions encoded by the Dynamin superfamily in eukaryotes.
- Open Access
Indels allow antiviral proteins to evolve functional novelty inaccessible by missense mutations
Antiviral proteins often evolve rapidly at virus-binding interfaces to defend against new viruses. We investigated whether antiviral adaptation via missense mutations might face limits, which insertion or deletion mutations (indels) could overcome. We report one such case of a nearly insurmountable evolutionary challenge: the human anti-retroviral protein TRIM5α requires more than five missense mutations in its specificity-determining v1 loop to restrict a divergent simian immunodeficiency virus (SIV). However, duplicating just one amino acid in v1 enables human TRIM5α to potently restrict SIV in a single evolutionary step. Moreover, natural primate TRIM5α v1 loops have evolved indels that confer novel antiviral specificities. Thus, indels enable antiviral proteins to overcome viral challenges inaccessible by missense mutations, revealing the potential of these often-overlooked mutations in driving protein innovation.
Open AccessIndels allow antiviral proteins to evolve functional novelty inaccessible by missense mutations
Antiviral proteins often evolve rapidly at virus-binding interfaces to defend against new viruses. We investigated whether antiviral adaptation via missense mutations might face limits, which insertion or deletion mutations (indels) could overcome. We report one such case of a nearly insurmountable evolutionary challenge: the human anti-retroviral protein TRIM5α requires more than five missense mutations in its specificity-determining v1 loop to restrict a divergent simian immunodeficiency virus (SIV). However, duplicating just one amino acid in v1 enables human TRIM5α to potently restrict SIV in a single evolutionary step. Moreover, natural primate TRIM5α v1 loops have evolved indels that confer novel antiviral specificities. Thus, indels enable antiviral proteins to overcome viral challenges inaccessible by missense mutations, revealing the potential of these often-overlooked mutations in driving protein innovation.
- 26 April 2022
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 40 (1) , 271-294
Evolutionary Landscapes of Host-Virus Arms Races
Vertebrate immune systems suppress viral infection using both innate restriction factors and adaptive immunity. Viruses mutate to escape these defenses, driving hosts to counterevolve to regain fitness. This cycle recurs repeatedly, resulting in an evolutionary arms race whose outcome depends on the pace and likelihood of adaptation by host and viral genes. Although viruses evolve faster than their vertebrate hosts, their proteins are subject to numerous functional constraints that impact the probability of adaptation. These constraints are globally defined by evolutionary landscapes, which describe the fitness and adaptive potential of all possible mutations. We review deep mutational scanning experiments mapping the evolutionary landscapes of both host and viral proteins engaged in arms races. For restriction factors and some broadly neutralizing antibodies, landscapes favor the host, which may help to level the evolutionary playing field against rapidly evolving viruses. We discuss the biophysical underpinnings of these landscapes and their therapeutic implications.
- 26 April 2022
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 40 (1) , 271-294
Evolutionary Landscapes of Host-Virus Arms Races
Vertebrate immune systems suppress viral infection using both innate restriction factors and adaptive immunity. Viruses mutate to escape these defenses, driving hosts to counterevolve to regain fitness. This cycle recurs repeatedly, resulting in an evolutionary arms race whose outcome depends on the pace and likelihood of adaptation by host and viral genes. Although viruses evolve faster than their vertebrate hosts, their proteins are subject to numerous functional constraints that impact the probability of adaptation. These constraints are globally defined by evolutionary landscapes, which describe the fitness and adaptive potential of all possible mutations. We review deep mutational scanning experiments mapping the evolutionary landscapes of both host and viral proteins engaged in arms races. For restriction factors and some broadly neutralizing antibodies, landscapes favor the host, which may help to level the evolutionary playing field against rapidly evolving viruses. We discuss the biophysical underpinnings of these landscapes and their therapeutic implications.
- Open Access
- 15 September 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Mutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races
Host antiviral proteins engage in evolutionary arms races with viruses, in which both sides rapidly evolve at interaction interfaces to gain or evade immune defense. For example, primate TRIM5α uses its rapidly evolving ‘v1’ loop to bind retroviral capsids, and single mutations in this loop can dramatically improve retroviral restriction. However, it is unknown whether such gains of viral restriction are rare, or if they incur loss of pre-existing function against other viruses. Using deep mutational scanning, we comprehensively measured how single mutations in the TRIM5α v1 loop affect restriction of divergent retroviruses. Unexpectedly, we found that the majority of mutations increase weak antiviral function. Moreover, most random mutations do not disrupt potent viral restriction, even when it is newly acquired via a single adaptive substitution. Our results indicate that TRIM5α’s adaptive landscape is remarkably broad and mutationally resilient, maximizing its chances of success in evolutionary arms races with retroviruses.
- 15 September 2020
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 9
Open AccessMutational resilience of antiviral restriction favors primate TRIM5α in host-virus evolutionary arms races
Host antiviral proteins engage in evolutionary arms races with viruses, in which both sides rapidly evolve at interaction interfaces to gain or evade immune defense. For example, primate TRIM5α uses its rapidly evolving ‘v1’ loop to bind retroviral capsids, and single mutations in this loop can dramatically improve retroviral restriction. However, it is unknown whether such gains of viral restriction are rare, or if they incur loss of pre-existing function against other viruses. Using deep mutational scanning, we comprehensively measured how single mutations in the TRIM5α v1 loop affect restriction of divergent retroviruses. Unexpectedly, we found that the majority of mutations increase weak antiviral function. Moreover, most random mutations do not disrupt potent viral restriction, even when it is newly acquired via a single adaptive substitution. Our results indicate that TRIM5α’s adaptive landscape is remarkably broad and mutationally resilient, maximizing its chances of success in evolutionary arms races with retroviruses.
- Open Access
- 24 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18832-18839
Induced proximity of a TIR signaling domain on a plant-mammalian NLR chimera activates defense in plants
Significance: Animal NLRs form wheel-like structures called inflammasomes upon perception of pathogen-associated molecules. The induced proximity of the signaling domains at the center of the wheel is hypothesized to recruit caspases for the first step of immune signal transduction. We expressed a plant-animal NLR fusion to demonstrate that induced proximity of TIR signaling domains from plant NLRs is sufficient to activate plant immune signaling. This demonstrates that a signaling-competent inflammasome can be formed from known, minimal components. The intrinsic NADase activity of plant TIRs is necessary for immune signaling, but fusions to a bacterial or a mammalian TIR domain with NADase activity, which also lead to accumulation of NAD + hydrolysis products (e.g. cyclic ADP-ribose), were unable to activate immune signaling.
- 24 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (31) , 18832-18839
Open AccessInduced proximity of a TIR signaling domain on a plant-mammalian NLR chimera activates defense in plants
Significance: Animal NLRs form wheel-like structures called inflammasomes upon perception of pathogen-associated molecules. The induced proximity of the signaling domains at the center of the wheel is hypothesized to recruit caspases for the first step of immune signal transduction. We expressed a plant-animal NLR fusion to demonstrate that induced proximity of TIR signaling domains from plant NLRs is sufficient to activate plant immune signaling. This demonstrates that a signaling-competent inflammasome can be formed from known, minimal components. The intrinsic NADase activity of plant TIRs is necessary for immune signaling, but fusions to a bacterial or a mammalian TIR domain with NADase activity, which also lead to accumulation of NAD + hydrolysis products (e.g. cyclic ADP-ribose), were unable to activate immune signaling.